Home
  • E-mailAnne.Stavelin@uib.no
  • Visitor Address
    Alrek helseklynge, blokk D, Årstadveien 17
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2021). Feasibility for aggregation of commutable external quality assessment results to evaluate metrological traceability and agreement among results. Clinical Chemistry and Laboratory Medicine. 117-125.
  • Show author(s) (2020). Performance of Afinion HbA1c measurements in general practice as judged by external quality assurance data. Clinical Chemistry and Laboratory Medicine. 588-596.
  • Show author(s) (2020). Harmonising EQA schemes the next frontier: Challenging the status quo. Clinical Chemistry and Laboratory Medicine. 1795-1797.
  • Show author(s) (2019). Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM). Clinical Chemistry and Laboratory Medicine. 1511-1521.
  • Show author(s) (2019). Commutability of a whole-blood external quality assessment material for point-of-care C-reactive protein, glucose, and hemoglobin testing. Clinical Chemistry. 791-797.
  • Show author(s) (2018). Harmonization activities of Noklus - A quality improvement organization for point-of-care laboratory examinations. Clinical Chemistry and Laboratory Medicine. 106-114.
  • Show author(s) (2017). Analytical performance specifications for external quality assessment - Definitions and descriptions. Clinical Chemistry and Laboratory Medicine. 949-955.
  • Show author(s) (2016). The importance of reagent lot registration in external quality assurance/proficiency testing schemes. Clinical Chemistry. 708-715.
  • Show author(s) (2016). Effect of participating in a quality improvement system over time for point-of-care c-reactive protein, glucose, and hemoglobin testing. Clinical Chemistry. 1474-1481.
  • Show author(s) (2015). Egenkontroll av warfarinbehandling. Tidsskrift for Den norske legeforening. 849-853.
  • Show author(s) (2014). The influence of coagulation factors on the in-treatment biological variation of international normalized ratio for patients on warfarin. Scandinavian Journal of Clinical and Laboratory Investigation. 470-476.
  • Show author(s) (2013). External quality assessment of point-of-care methods: model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials. Clinical Chemistry. 363-371.
  • Show author(s) (2012). The Accu-Chek Mobile blood glucose monitoring system used under controlled conditions meets ISO 15197 standards in the hands of diabetes patients. Scandinavian Journal of Clinical and Laboratory Investigation. 374-379.
  • Show author(s) (2012). External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe. Clinical Chemistry and Laboratory Medicine. 81-88.
  • Show author(s) (2012). Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments. Clinical Chemistry and Laboratory Medicine. 1611-1620.
  • Show author(s) (2010). Discrepancies in International Normalized Ratio Results between Instruments: A Model to Split the Variation into Subcomponents. Clinical Chemistry. 1618-1626.
  • Show author(s) (2009). Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials. Thrombosis and Haemostasis. 593-600.
  • Show author(s) (2006). External quality assessment of prothrombin time: The split-sample model compared with external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 337-349.
Reader opinion piece
  • Show author(s) (2007). Response to Kitchen et al.'s external quality assessment of prothrombin time: The split-sample model compared to external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 676-677.
Short communication
  • Show author(s) (2005). Analyse av protrombintid i primærhelsetjenesten. Tidsskrift for Den norske legeforening. 2048-2049.
Feature article
  • Show author(s) (2017). Bioingeniører må forske på eget fag :. Bioingeniøren. 22-23.
Letter to the editor
  • Show author(s) (2017). Effect of dabigatran treatment at therapeutic levels on point-of-care international normalized ratio (INR). Clinical Chemistry and Laboratory Medicine. e143-e145.
Doctoral dissertation
  • Show author(s) (2013). Analytical quality control of INR measurements in primary care.
Abstract
  • Show author(s) (2013). Pre-analytical routines in coagulation testing: are guidelines followed? Journal of Thrombosis and Haemostasis. 18-18.
  • Show author(s) (2005). External quality assessments of whole blood prothrombin time: Comparison of two methods. Clinica Chimica Acta.
Academic literature review
  • Show author(s) (2017). Essential aspects of external quality assurance for point-of-care testing. Biochemia Medica. 81-85.
  • Show author(s) (2017). An overview of the European organization for external quality assurance providers in laboratory medicine (EQALM). Biochemia Medica. 30-36.

More information in national current research information system (CRIStin)